Post on 14-Jan-2017
transcript
Accepted manuscripts are peer-reviewed but have not been through the copyediting, formatting, or proofreadingprocess.
Copyright © 2016 the authors
This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version.
Research Articles: Behavioral/Cognitive
Loss of plasticity in the D2-accumbens pallidal pathway promotes cocaine seeking
J.a. Heinsbroek1,*, D.n. Neuhofer1,*, W.c. Griffin2, G.s. Siegel2, A-C Bobadilla1, Y.m. Kupchik3,+ and P.w. Kalivas1,2,
+
1Department of Neuroscience, Medical University of South Carolina, Charleston, SC2Department of Psychiatry and Behavioral Science, Medical University of South Carolina, Charleston, SC3Department of Neuroscience, Hebrew University, Jerusalem, Israel
DOI: 10.1523/JNEUROSCI.2659-16.2016
Received: 22 August 2016
Revised: 15 November 2016
Accepted: 28 November 2016
Published: 1 December 2016
Author contributions: J.A.H., D.N.N., Y.M.K., and P.W.K designed research; J.A.H., D.N.N., G.W.C., Y.M.K.,W.C.G., G.S.S. and B.A-C. performed research; J.A.H., D.N.N., Y.M.K., and P.W.K analyzed data; J.A.H. andP.W.K. wrote the paper.
This research was supported in part by USPHS grants DA012512, DA003906 and DA015369. We thank Dr.Jamie Peters and the members of the Kalivas lab for helpful comments on the manuscript, and thank VictoriaCharensouk and Lauryn Luderman for technical assistance.
Correspondence should be addressed to Jasper Heinsbroek and Peter Kalivas, Medical University of SouthCarolina, Drug Discovery Building 223, 70 President St, Charleston, SC 29425. Email: heinsbro@musc.edu andkalivasp@musc.edu
Cite as: J. Neurosci 2016; 10.1523/JNEUROSCI.2659-16.2016
Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formattedversion of this article is published.
Cocaine self-administration, extinction and reinstatement.
Sucrose self-administration, extinction and reinstatement.
120
40
80
120
Lever
Pre
sses (
2h
)
Self-administration
61 1 6
Extinction
10
D1-CreA
NeuN
Gs-DREADDDARPP-32
ac
D
V
M L
BDays
Active Lever Active Lever
Inactive Lever
Infusions Inactive Lever
D2-Cre
0
40
80
120
Lever
Pre
sses (
2h
)
1261 1 6 10
that could contribute to the bidirectional regulation of cocaine seeking!
A
0 5 10 15 200
50
100
150
% C
on
tro
l IP
SC
D1D2
Control
CNO
Time (min)
NAcore
Gi-DREADD
ac ac
dlVP
vmVP
NAcore
ChR2
ac ac
dlVP
vmVP
D
V
A P
B
ac
Met-Enkephalin
Gi-DREADD
D
V
L MCPu
dlVP
BST
IPAC
CNOVeh0
40
80
CNO
NAc Gs-DREADD
NAc Gs-DREADD
*Infusions
Inactive Lever
60
60
0
0
D E
D1-Cre
Vo
lta
ge
Ch
an
ge
(m
V)
-5 0 5 10-10
-5
0
5
Active
Le
ve
r P
resse
s (
2h
)
Time (min)
C
CNO
GFSelf-Admin
Extinction
Cue Test
116
5 7 7n = 8
+ VP Gi-DREADD
Le
ve
r P
resse
s (
2h
)
*Active Lever
CNOVeh
60
60
0
0
Self-Admin
Extinction
Le
ve
r P
resse
s (
2h
)
Gs-DREADD
Cue Test
D2-Cre0
40
80
BA
ic
lv
BST
VP
SI
DBH
LH
ac
cc
f
ac
CPu
dlVP
D
V
M L
Gi-DREADD
Gs-DREADD
Gs-DREADD
Gi-DREADD
NAcore
dlVP
Infusions
Inactive Lever
Active Lever
Active
Le
ve
r P
resse
s (
2h
)
ac
ac
NAcore
NAshell
CPuD
V
A P
dlVP
IPAC
Gi-DREADD
Gi-DREADD
Gi-DREADD
Gi-DREADD
A
B
NAc Gi-DREADD
*
NAc Gi-DREADD
+VP Gi-DREADD
11 6
5
D
CNOVeh0
40
80
CNO
*
60
60
0
0
Self-Admin
Extinction
C
Le
ve
r P
resse
s (
2h
)
D2-Cre
60
60
0
0
E
Le
ve
r P
resse
s (
2h
)
Self-Admin
Extinction
6 6
F
Gi-DREADD
0
40
80
CNOVehD1-Cre
NAcore
dlVP
Infusions
Inactive Lever
Active Lever
Infusions
Inactive Lever
Active Lever
Active
Le
ve
r P
resse
s (
2h
)
Active
Le
ve
r P
resse
s (
2h
)
CNOVeh
6 60
40
80
CNOVeh
6 60
40
80
Cue Test
120
50
100
150
Days
Lever
Pre
sses (
2h)
Self Administration
61
Active Lever
Pellets
Inactive Lever
A
C
1 5 10
Extinction
0
200
400
B
Extinction
D1-Cre
Lever
Pre
sses (
2h)
Self Administration
0
50
100
150
Lever
Pre
sses (
2h)
1261 1 5 10
Days
0
200
400
Lever
Pre
sses (
2h)
D
CNOVeh
5 60
80
160
CNOVeh
4 40
80
160
Sucrose Primed
Cue Test
*
Cue Test
D2-Cre
Sucrose Primed
Cue Test
Active
Le
ve
r P
resse
s (
2h
)
Active
Le
ve
r P
resse
s (
2h
)
Active
Le
ve
r P
resse
s (
2h
)
Active
Le
ve
r P
resse
s (
2h
)
Active Lever
Pellets
Inactive Lever
Active Lever
Inactive Lever
Active Lever
Inactive Lever
B
-5 0 5 10 15
50
100
150
D1D2
C
G
ac
VP
ic
*
NAcore
NAshell
dlVP
A
vmVP
ac
IPAC
**
-5 0 5 10
50
100
D2D1
F
50
100
150
50
100
150
D1 D2
D1 D2
D
0
1
2
**
pre post pre post
E
*
pre post pre post
*
H
8/7 9/5
6/3 9/5
% B
ase
line
IP
SC
Pa
ire
d P
uls
e R
atio
Time (min)
0
1
2
Pa
ire
d P
uls
e R
atio
% B
ase
line
IP
SC
% B
ase
line
IP
SC
% B
ase
line
IP
SC
Time (min)
50 ms
40
0 p
A
50 ms
50
0 p
A
ChR2
40
0 p
A
8/7 9/5
6/5 7/4
50 ms
40
0 p
A
50 ms
HFS
Control
Cocaine
15
HFS
*
A
-5 0 5 10 15
Time (min)
D2
CTOP
HFS
D1
C
50
100
150
200
50
100
150
200E
D
F
B
D1 D2
10/6 5/5
8/7 6/5
Control
% B
ase
line
IP
SC
% B
ase
line
IP
SC
% B
ase
line
IP
SC
% B
ase
line
IP
SC
% B
ase
line
IP
SC
% B
ase
line
IP
SC
-5 0 5 10 15
Time (min)
D1 D2
D2D1
Control
CTOP
-5 0 5 10 15
Time (min)D1 D2
CTOP
D2D1
Cocaine
50
100
150
200
50
100
150
200
25 ms
50
0 p
A
25 ms
50
0 p
A
25 ms
50
0 p
A
50
100
150
200
0
0
50
100
150
200
09/7 12/9
*
*